Skip to content

Clinical Study on the Efficacy of Accelerated Transcranial Magnetic Stimulation in Improving Ataxia in Patients with Multiple System Atrophy-Cerebellar Type

Clinical Study on the Efficacy of Accelerated Transcranial Magnetic Stimulation in Improving Ataxia in Patients with Multiple System Atrophy-Cerebellar Type

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099484
Enrollment
Unknown
Registered
2025-03-25
Start date
2025-03-27
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple System Atrophy-cerebellar type

Interventions

real group:Transcranial Magnetic Stimulation
Sham stimulation group:Sham stimulation using a dummy coil

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with Multiple System Atrophy - Cerebellar type (MSA-C) who meet the diagnostic criteria for clinical diagnosis or probable MSA-C according to the Chinese Expert Consensus on the Diagnosis of Multiple System Atrophy (2022); 2. No other neurodegenerative diseases; 3. Aged between 45 and 75 years, with no gender restrictions; 4. Willing to participate in the study and provide written informed consent; 5. Able to fully comply with the treatment and complete a 2-month follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with severe internal medical conditions, psychiatric disorders, or those without legal capacity or with restricted legal capacity; 2. Patients with significant abnormalities found in relevant tests and examinations (such as biochemical blood tests or abnormal electrocardiograms); 3. Patients with metal foreign bodies in the skull, cardiac pacemakers, cardiac stents, or cochlear implants; 4. Patients with intracranial infections, acute cerebral hemorrhage, or significantly elevated intracranial pressure; 5. Patients with a history of epilepsy or a family history of epilepsy, or those currently using bupropion or other medications that may increase the risk of TMS-induced seizures; 6. Patients with severe hearing or visual impairments that prevent cooperation with examinations; 7. Patients with pacemakers, aneurysm clips, artificial heart valves, cochlear implants, metal fragments, or foreign bodies in the eyes, skin, or body that are contraindications for MRI scanning.

Design outcomes

Primary

MeasureTime frame
the ScalefortheAssessment and Rating of Ataxia (SARA);

Secondary

MeasureTime frame
UMSARS,SARA,Berg balance scale;brain network;

Countries

China

Contacts

Public ContactHua Lin

Xuanwu Hospital Capital Medical University

linhuadoctor@163.com+86 135 2016 3017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026